The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients

International Immunopharmacology

Volumn 6, Issue 13-14, 2006, Pages 2031-2037

  Nogueira, Eliana ^a,b   Ozaki, Kikumi S ^a   Tomiyama, Helena ^b   Granato, Celso F H ^b   Camara, Niels O S ^a,c   Silva, Alvaro Pacheco e ^a  

^a Nephrology Division   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CMV; Ganciclovir; Kidney transplant; Resistance; UL97

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; DNA POLYMERASE; FOSCARNET; GANCICLOVIR; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN UL97; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; NUCLEOTIDE SEQUENCE; PANCREAS TRANSPLANTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TREATMENT PLANNING; VIREMIA; VIRUS LOAD; VIRUS RESISTANCE; VIRUS STRAIN;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; FEMALE; GANCICLOVIR; GENOTYPE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); VIRAL ENVELOPE PROTEINS; VIRAL LOAD;

EID: 33845214006     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.07.022     Document Type: Article

References (33)

1. Mocarski E.S. Cytomegalovirus and their replication. In: Fields D.N., Knipe D.M., and Howleyp M. (Eds). Fields virology (1996), Lippincott-Raven, Philadelphia 2447-2492
2. Opelz G., Dohler B., and Ruhenstroth A. Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant 4 6 (2004) 928-936
3. Campino A. Gancyclovir prophylaxis in high risk patients. Transpl Proc 37 10 (2005) 4311-4312
4. Ozaki K.S., Pestana J.O., Granato C.F., Pacheco-Silva A., and Camargo L.F. Sequenctial cytomegalovirus antigenemia monitoring in kidney transplant patients treated with antilymphocyte antibodies. Transpl Infect Dis 6 2 (2004) 63-68
5. Chou S., Guentzel S., Michels K.R., Miner R.C., and Drew W.L. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J Infect Dis 172 (1995) 239-242
6. Balfour H.H. Antiviral drugs. N Engl J Med 340 16 (1999) 1255-1268
7. Kletzmayr J., Kreuzwieser E., Watkins-Riedel T., Berlakovich G., Kovarik J., and Klauser R. Long-term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalovirus high-risk renal transplant recipients. Transplantation 70 (2000) 1174-1180
8. Bueno J., Ramil C., and Green M. Current management strategies for the prevention and treatment of cytomegalovirus infection in paediatric transplant recipients. Paediatr Drugs 4 5 (2002) 279-290
9. Mousavi-Jazi M., Hokeberg I., Schloss L., Zweygberg-Wigart B., Grillner L., Linda A., et al. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment. Transplant Infect Dis 3 4 (2001) 195-202
10. Erice A. Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 12 (1999) 286-297
11. Sullivan V., Biron K.K., Talarico C., Stanat S.C., Davis M., Pozzi L.M., et al. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Ant Agents Chem 37 1 (1993) 19-25
12. Boivin G., Gilbert C., Morissette M., Handfield J., Goyette N., and Bergeron M.G. A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS: logitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments. AIDS 11 (1997) 867-873
13. Erice A., Gil-Roda C., Perez J.L., Balfour Jr. H.H., Sannerud K.J., Hanson M.N., et al. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. J Infect Dis 175 (1997) 1087-1092
14. Liu W., Shum C., Martin D.F., Kuppermann B.D., Hall A.J., and Margolis T.P. Prevalence of antiviral drug resistance in untreated patients with cytomegalovirus retinitis. J Infect Dis 182 (2000) 1234-1238
15. Lurain N.S., Ammons H.C., Kapell K.S., Yeldandi V.V., Garrity E.R., and O'Keefe J.P. Molecular analysis of human cytomegalovirus strains from two lung transplant recipients with the same donor. Transplantation 62 (1996) 497-502
16. Rosen H.R., Benner K.G., Flora K.D., Rabkin J.M., Orloff S.L., Olyaei A., et al. Development of ganciclovir resistance during treatment of primary cytomegalovirus infection after liver transplantation. Transplantation 63 (1997) 476-478
17. Alain S., Honderlick P., Grenet D., Stern M., Vadam C., Sanson-Le Pors M.J., et al. Failure of ganciclovir treatment associated with selection of a ganciclovir-resistant cytomegalovirus strain in a lung transplant recipient. Transplantation 63 (1997) 1533-1536
18. Limaye A.P., Corey L., Loelle D.M., Davis C.L., and Boeckh M. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants. Lancet 356 (2000) 645-649
19. van der Bij W., Schirm J., Torensma R., van Son W.J., Tegzess A.M., and The T.H. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J Med Virol 25 (1998) 179-188
20. Baldanti F., Underwood M.R., and Stanat S.C. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-grow phenotype, while mutations in the UL97-encoded phosphotransferease confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol 70 (1996) 1390-1395
21. Boivin G., Chou S., Quirk M.R., Erice A., and Jordan M.C. Detection of ganciclovir resistance mutations and quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J Infect Dis 173 (1996) 523-528
22. Chou S., and Dennison K.M. Analysis of interstrain variation in cytoegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 163 (1991) 1229-1234
23. Prix L., Hamprecht K., Holzhuter B., Handgretinger R., Klingebiel T., and Jahn G. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J Infect Dis 180 (1999) 491-495
24. Jabs D.A., Martin B.K., Forman M.S., Dunn J.P., Davis J.L., Weigberg D.V., et al. Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8. Am J Ophthalmol 132 5 (2001 (Nov)) 700-710
25. Wolf D.G., Lurain N.S., Zuckerman T., Hoffman R., and Satinger J. Emergence of late cytomegalovirus central nervous system disease in hematopoietic stem cell transplant recipients. Blood 101 2 (2003) 463-465
26. Mylonakis E., Kakkas W.M., and Fishman J.A. Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients. Clin Infect Dis 34 15 (2002) 1337-1341
27. Emery V.C., and Griffiths P.D. Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy. Proc Natl Acad Sci U S A 97 (2000) 8039-8044
28. Chou S. Antiviral drug resistance in human cytomegalovirus. Transpl Infect Dis 1 2 (1999) 105-114
29. Smith I.L., Cherrington J.M., Jiles R.E., Fuller M.D., Freeman W.R., and Spector S.A. High-levels resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis 176 (1997) 69-77
30. Drew W.L., Paya C.V., and Emery V. Cytomegalovirus (CMV) resistance to antivirals. Am J Transplantation 1 (2001) 307-312
31. Drew W.L., Miner R.C., Busch D.F., Follansbee S.E., Gullett J., and Mehalko S.G. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis 172 (1991) 239-242
32. Bowen E.F., Emery V.C., Busch D.F., Johnson M.A., Davey C.C., et al. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis. AIDS 10 (1998) 605-611
33. Aquino V.H., and Figueiredo T. High Prevalence of renal transplant recipients infected with more than one cytomegalovirus glycoprotein B genotype. J Med Virol 61 (2000) 138-142